|By PR Newswire||
|April 21, 2014 12:15 PM EDT||
FALLS CHURCH, Va., April 21, 2014 /PRNewswire-USNewswire/ -- Acentia, a premier provider of technology and management solutions, today announced it was awarded a 1-year, $2.5-million contract by the U.S. Patent and Trademark Office (USPTO). The company will provide software design and development services to develop and implement Phase 2 of the Agency's Cooperative Patent Classification (CPC) Database project.
The CPC effort is a joint partnership between the USPTO and the European Patent Office (EPO) where the Offices have agreed to harmonize their existing classification systems (European Classification (ECLA) and United States Patent Classification (USPC), respectively) and migrate towards a common classification structure.
Acentia will enhance the existing CPC applications to allow the patent examiners improved access to CPC symbols and allocations, as well as respond to EPO Raised Hand Flags (RHF). The company will also analyze the CPC functional requirements to increase system performance and help patent examiners perform their duties more efficiently.
"We are honored that Acentia has been selected to again support the U.S. Patent and Trademark Office," said David Shuping, Acentia Sector Executive. "The CPC work complements our current portfolio of USPTO projects and establishes Acentia as a trusted partner with the Agency."
In addition to this new award, Acentia currently performs the operations and maintenance of the USPTO's mission-critical Patent Application Location and Monitoring (PALM) systems and provides software development services for its PALM and other legacy Patent systems.
Acentia is a premier employer and provider of technology and management solutions to public sector healthcare and Federal Government civilian customers. Our professionals build trusted partnerships with our customers by tackling their most difficult challenges on programs of national significance while consistently demonstrating value to our customers and the American taxpayer. For more information, visit www.acentia.com. Follow us on Twitter @Acentia.com.